Intratumoral submicron particle docetaxel inhibits syngeneic Renca renal cancer growth and increases CD4+, CD8+, and Treg levels in peripheral blood. [electronic resource]
Producer: 20210902Description: 1618-1626 p. digitalISSN:- 1573-0646
- Animals
- Antineoplastic Agents -- administration & dosage
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Carcinoma, Renal Cell -- blood
- Cell Line, Tumor
- Docetaxel -- administration & dosage
- Female
- Kidney Neoplasms -- blood
- Mice, Inbred BALB C
- Nanoparticles -- administration & dosage
- T-Lymphocytes, Regulatory -- drug effects
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.